Goldman Sachs to resume bets on US property, other investors warn of more pain
By Iain Withers CANNES, France (Reuters) – Goldman Sachs Asset Management will resume “actively investing” in U.S. commercial property this…
Month: March 2024
S&P 500 posts record high close as Oracle jumps, traders keep rate-cut bets
By Caroline Valetkevitch NEW YORK (Reuters) -U.S. stocks ended sharply higher on Tuesday, with the S&P 500 registering a record…
Arm’s shares rise as Wall Street eyes IPO lock-up expiration
By Chibuike Oguh NEW YORK (Reuters) -Shares of Arm Holdings, the British chip designer backed by Softbank Group, gained 2.1%…
Trump’s defense in hush money trial to stop short of blaming his lawyers
By Luc Cohen NEW YORK (Reuters) – Donald Trump will stop short of blaming his lawyers for the conduct at…
Boeing will add compliance checks, equipment audits at 737 factory, memo says
By David Shepardson (Reuters) – Boeing <BA.N> is adding weekly compliance checks for every 737 work area and additional audits…
S&P 500, Nasdaq end down as investors wait for CPI, PPI data
By Caroline Valetkevitch NEW YORK (Reuters) -The S&P 500 and Nasdaq ended down slightly on Monday with investors preparing for…
Oracle tops quarterly profit estimates on AI demand, shares surge
By Harshita Mary Varghese (Reuters) -Oracle said on Monday it is set to make a joint announcement with chip-giant Nvidia,…
Yen rises as investors eye Japan policy move; bitcoin soars to new record
By Gertrude Chavez-Dreyfuss NEW YORK (Reuters) – The yen drifted higher against the U.S. dollar for a fourth straight session…
Bitcoin hits record above $72,000 as demand frenzy intensifies
By Hannah Lang, Amanda Cooper and Harry Robertson WASHINGTON/LONDON (Reuters) -Bitcoin hit a record high on Monday above $72,000, as…
US FDA approves Novo Nordisk’s Wegovy for lowering heart risks
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration approved Novo Nordisk’s weight-loss drug Wegovy on…